CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment

Hepatocellular carcinoma (HCC) is a lethal malignancy with a lack of effective treatments particularly for the disease at an advanced stage. Even though immune checkpoint inhibitors (ICIs) have made great progress in the treatment of HCC, durable and ideal clinical benefits still cannot be achieved...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Rui, Li, Jiayin, Hony, Jing, Xiao, Zhiwei, wang, Jinghui, Yao, Man, Liang, Shufang, Lu, Lingeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061011/
https://www.ncbi.nlm.nih.gov/pubmed/37006233
http://dx.doi.org/10.3389/fimmu.2023.1052657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061011/
https://www.ncbi.nlm.nih.gov/pubmed/37006233
http://dx.doi.org/10.3389/fimmu.2023.1052657

Ejemplares similares